Curis to Release Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call on February 20, 2014

[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, today announced that the Company will release its fourth quarter … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view